BETHANY RISEN: Open Payments
NPI 1790564912 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $45 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $77 |
| Alnylam Pharmaceuticals Inc. | 3 | $66 |
| BridgeBio Pharma, Inc. | 2 | $54 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| PFIZER INC. | 3 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: FARXIGA, ONPATTRO, Attruby, VYNDAQEL, Kerendia, VERQUVO, FUROSCIX, JARDIANCE.
Industry payments across KY — which companies pay providers there.
